PFS Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
PFS Investments's BIIB Position: Q2 2023 in Review
PFS Investments reduced its Biogen (BIIB) stake by 0.73% in Q2 2023, selling an estimated $51.8K and leaving 23,563 shares worth $6.71M. The position accounts for 0.11% of the portfolio, ranked #181.
PFS Investments first reported a position in BIIB in Q1 2019 and has held it in 18 quarters since. The position peaked at $10.6M in Q2 2021. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.
- PFS Investments held 23,563 shares of Biogen worth $6.71M as of Q2 2023.
- PFS Investments sold 174 Biogen shares in Q2 2023, an estimated $51.8K.
- Biogen made up 0.11% of PFS Investments's portfolio in Q2 2023, its #181 holding.
- PFS Investments first reported a position in Biogen in Q1 2019 and has held it in 18 quarters since.
- PFS Investments's Biogen position peaked at $10.6M in Q2 2021.
- 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.
Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.